Proto-oncogene expression: a predictive assay for radiation biodosimetry applications

Area of Science:

• Molecular Biology
• Radiation Biology
• Genetics

Background:

• Proto-oncogene expression is critical in cellular regulation.
• Understanding radiation's impact on gene expression is vital for biodosimetry.
• Low-dose radiation effects on specific proto-oncogenes require further investigation.

Purpose of the Study:

• To investigate the effect of low-dose X-ray radiation on proto-oncogene expression in human lymphocytes.
• To identify potential molecular biomarkers for radiation biodosimetry.

Main Methods:

• In vitro human peripheral blood lymphocytes were exposed to low-dose X-ray radiation (0.25-1.50 Gy).
• RNA was extracted at various time points (0.25-17 h) post-irradiation.
• Northern blot hybridization was used to quantify mRNA levels of c-Haras, c-src, c-met, c-jun, c-fos, c-myc, and beta-actin.

Main Results:

• A time- and dose-dependent increase in c-Haras mRNA levels was observed.
• Expression of other proto-oncogenes (c-src, c-met, c-fos, c-jun, c-myc) showed variable responses.
• Beta-actin mRNA levels initially decreased but recovered by 17 hours post-radiation.
• c-Haras transcription rates were higher at 5 h compared to 17 h post-irradiation.

Conclusions:

• Specific proto-oncogene expression, particularly c-Haras, may serve as early diagnostic molecular biomarkers for radiation biodosimetry.
• Real-time PCR technologies can be utilized for quantifying gene expression changes in biodosimetry applications.